{"id":5876,"date":"2024-11-29T15:51:58","date_gmt":"2024-11-29T15:51:58","guid":{"rendered":"https:\/\/regtechafrica.com\/healthcare\/?p=5876"},"modified":"2024-11-29T15:51:58","modified_gmt":"2024-11-29T15:51:58","slug":"nigeria-malaria-vaccination-campaign-to-begin-in-kebbi-and-bayelsa-on-december-2","status":"publish","type":"post","link":"https:\/\/regtechafrica.com\/healthcare\/nigeria-malaria-vaccination-campaign-to-begin-in-kebbi-and-bayelsa-on-december-2\/","title":{"rendered":"Nigeria: Malaria Vaccination Campaign to Begin in Kebbi and Bayelsa on December 2"},"content":{"rendered":"

The National Primary Health Care Development Agency (NPHCDA)<\/strong> has announced that the highly anticipated malaria vaccination campaign will kick off in Kebbi<\/strong> and Bayelsa States<\/strong> on December 2, 2024<\/strong>. This initiative represents a critical step in Nigeria\u2019s ongoing fight against malaria, one of the country\u2019s leading causes of illness and death.<\/p>\n

Executive Director of the NPHCDA, Dr. Muyi Aina<\/strong>, revealed the development during a press briefing in Abuja on Friday, emphasizing that the campaign targets children under five years of age<\/strong>, the group most vulnerable to malaria.<\/p>\n

A Strategic Leap in Malaria Prevention<\/strong><\/h3>\n

The malaria vaccine, developed by Oxford University<\/strong> and produced by the Serum Institute of India<\/strong> and Novavax<\/strong>, has demonstrated significant efficacy during trials. It will be provided free of charge<\/strong> and is expected to complement existing prevention measures<\/strong>, including the widespread use of insecticide-treated nets<\/strong> and antimalarial medications<\/strong>.<\/p>\n

\u201cThe launch of the malaria vaccine in Kebbi and Bayelsa marks a pivotal moment in our efforts to combat malaria, a disease that continues to claim thousands of lives annually in Nigeria,\u201d Dr. Aina stated.<\/p><\/blockquote>\n

The vaccination drive aims to reach an estimated 1.5 million children<\/strong> across the two states. Health workers, supported by state governments and international partners such as the World Health Organization (WHO)<\/strong> and UNICEF<\/strong>, will administer the vaccine through home visits and health centres.<\/p>\n

Achieving Malaria Elimination Goals<\/strong><\/h3>\n

Dr. Aina highlighted the importance of this campaign in aligning with Nigeria\u2019s broader malaria control strategy<\/strong>, which seeks to reduce malaria cases by 40% by 2030<\/strong> in line with the WHO\u2019s Global Malaria Strategy<\/strong>.<\/p>\n

\u201cThis vaccine introduction is a safe and effective measure to save lives and prevent malaria-related illnesses. We urge residents in Kebbi and Bayelsa to actively participate in this life-saving initiative,\u201d he said.<\/p><\/blockquote>\n

Nigeria\u2019s Malaria Burden<\/strong><\/h3>\n

Malaria remains a significant public health challenge in Nigeria, which accounts for 31% of global malaria deaths<\/strong>. Each year, the disease claims over 600,000 lives worldwide<\/strong>, with children under five in sub-Saharan Africa being the most affected.<\/p>\n

The introduction of the malaria vaccine represents a landmark achievement<\/strong> in Nigeria\u2019s fight against this deadly disease and underscores the government\u2019s commitment to advancing universal health coverage<\/strong>.<\/p>\n

This vaccination effort is part of a wider strategy to reduce malaria prevalence and improve health outcomes for Nigeria’s most vulnerable populations, laying the groundwork for a future free of malaria.<\/p>\n","protected":false},"excerpt":{"rendered":"

The National Primary Health Care Development Agency (NPHCDA) has announced that the highly anticipated malaria vaccination campaign will kick off in Kebbi and Bayelsa States on December 2, 2024. This…<\/p>\n","protected":false},"author":1,"featured_media":5879,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[80,90],"tags":[],"class_list":["post-5876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-nigeria"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/regtechafrica.com\/healthcare\/wp-content\/uploads\/2024\/11\/GaGdOTpWIAA9Q00-scaled.jpeg.webp?fit=2560%2C1708&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/5876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/comments?post=5876"}],"version-history":[{"count":1,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/5876\/revisions"}],"predecessor-version":[{"id":5880,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/5876\/revisions\/5880"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/media\/5879"}],"wp:attachment":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/media?parent=5876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/categories?post=5876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/tags?post=5876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}